Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis.

Werbovetz, K A

Werbovetz, K A.

Affiliation

Werbovetz KA; Department of Parasitology, Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Washington, DC 20307, USA. karl.werbovetz@na.amedd.army.mil

Curr Med Chem ; 7(8): 835-60, 2000 Aug.

Article in En | MEDLINE | ID: mdl-10828290

Subject(s)

Antimalarials/pharmacology; Enzyme Inhibitors/pharmacology; Trypanocidal Agents/pharmacology; Animals; Antimalarials/chemistry; Antimalarials/therapeutic use; Biological Transport/drug effects; Chemistry, Pharmaceutical; Drug Evaluation, Preclinical; Enzyme Inhibitors/chemistry; Enzyme Inhibitors/therapeutic use; Humans; Leishmania/drug effects; Leishmania/physiology; Molecular Structure; Plasmodium/drug effects; Plasmodium/physiology; Trypanocidal Agents/chemistry; Trypanocidal Agents/therapeutic use; Trypanosoma/drug effects; Trypanosoma/physiology

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Trypanocidal Agents / Enzyme Inhibitors / Antimalarials Language: En Journal: Curr Med Chem Year: 2000 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links